1933 Industries Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
1933 Industries has been growing earnings at an average annual rate of 10.1%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 4% per year.
Key information
10.1%
Earnings growth rate
26.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 4.0% |
| Return on equity | n/a |
| Net Margin | -49.5% |
| Last Earnings Update | 30 Apr 2024 |
Recent past performance updates
Recent updates
1933 Industries Inc. (CSE:TGIF) Stock's 50% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Dec 22
Take Care Before Jumping Onto 1933 Industries Inc. (CSE:TGIF) Even Though It's 67% Cheaper
Oct 311933 Industries Inc. (CSE:TGIF) Might Not Be As Mispriced As It Looks After Plunging 50%
Sep 11Further Upside For 1933 Industries Inc. (CSE:TGIF) Shares Could Introduce Price Risks After 33% Bounce
Feb 221933 Industries Inc. (CSE:TGIF) Soars 33% But It's A Story Of Risk Vs Reward
Dec 22Is 1933 Industries (CSE:TGIF) Using Too Much Debt?
Aug 111933 Industries Inc.'s (CSE:TGIF) Popularity With Investors Is Under Threat From Overpricing
Jun 17Is 1933 Industries (CSE:TGIF) Weighed On By Its Debt Load?
Apr 10Does 1933 Industries (CSE:TGIF) Have A Healthy Balance Sheet?
Oct 15Is 1933 Industries (CSE:TGIF) Using Debt Sensibly?
Jun 30Does 1933 Industries (CSE:TGIF) Have A Healthy Balance Sheet?
Mar 17Auditors Have Doubts About 1933 Industries (CSE:TGIF)
Dec 02Is 1933 Industries (CSE:TGIF) A Risky Investment?
Oct 21Is 1933 Industries (CSE:TGIF) Using Too Much Debt?
Jul 08Revenue & Expenses Breakdown
How 1933 Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Apr 24 | 20 | -10 | 5 | 0 |
| 31 Jan 24 | 19 | -13 | 5 | 0 |
| 31 Oct 23 | 19 | -13 | 5 | 0 |
| 31 Jul 23 | 18 | -13 | 5 | 0 |
| 30 Apr 23 | 16 | -8 | 4 | 0 |
| 31 Jan 23 | 16 | -17 | 5 | 0 |
| 31 Oct 22 | 15 | -18 | 4 | 0 |
| 31 Jul 22 | 13 | -18 | 4 | 0 |
| 30 Apr 22 | 12 | -17 | 4 | 0 |
| 31 Jan 22 | 12 | -4 | 4 | 0 |
| 31 Oct 21 | 12 | -5 | 4 | 0 |
| 31 Jul 21 | 12 | -6 | 6 | 0 |
| 30 Apr 21 | 12 | -9 | 9 | 0 |
| 31 Jan 21 | 11 | -14 | 11 | 0 |
| 31 Oct 20 | 11 | -18 | 15 | 0 |
| 31 Jul 20 | 12 | -19 | 17 | 0 |
| 30 Apr 20 | 15 | -20 | 16 | 0 |
| 31 Jan 20 | 17 | -22 | 16 | 0 |
| 31 Oct 19 | 17 | -19 | 15 | 0 |
| 31 Jul 19 | 18 | -18 | 15 | 0 |
| 30 Apr 19 | 17 | -16 | 15 | 0 |
| 31 Jan 19 | 15 | -10 | 12 | 0 |
| 31 Oct 18 | 15 | -8 | 11 | 0 |
| 31 Jul 18 | 13 | -5 | 9 | 0 |
| 30 Apr 18 | 10 | -4 | 7 | 0 |
| 31 Jan 18 | 6 | -4 | 6 | 0 |
| 31 Oct 17 | 3 | -3 | 4 | 0 |
| 31 Jul 17 | 1 | -3 | 3 | 0 |
| 30 Apr 17 | 0 | -3 | 1 | 0 |
| 31 Jan 17 | 0 | -3 | 1 | 0 |
| 31 Oct 16 | 0 | -4 | 2 | 0 |
| 31 Jul 16 | 0 | -4 | 2 | 0 |
Quality Earnings: TGIF is currently unprofitable.
Growing Profit Margin: TGIF is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TGIF is unprofitable, but has reduced losses over the past 5 years at a rate of 10.1% per year.
Accelerating Growth: Unable to compare TGIF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TGIF is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).
Return on Equity
High ROE: TGIF's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:29 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/04/30 |
| Annual Earnings | 2023/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
1933 Industries Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Burleson | Canaccord Genuity |